ANVAING SOIN: what changed
ANVAING SOIN
Largest movements
- Cash +€22,751
up €22,751 (+64.3%), from €35,378 to €58,129
mainly Net result for the year (+€21,945) and Tax, wage and social debts (+€2,035)
- Profit (loss) carried forward +€21,945
up €21,945 (+101%), from €21,825 to €43,770
- Tax, wage and social debts +€2,035
up €2,035 (+465%), from €437 to €2,472
- Other debts -€1,625
down €1,625 (-24.2%), from €6,705 to €5,081
- Gross operating margin +€2,256
up €2,256 (+7.5%), from €30,012 to €32,268
- Taxes +€1,738
up €1,738 (+21.9%), from €7,937 to €9,675
- Other operating charges +€459
up €459 (+413%), from €111 to €570
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €35,378 | €58,129 | +€22,751 | +64.3% |
| Current assets | 29/58 | €35,378 | €58,129 | +€22,751 | +64.3% |
| Cash at bank and in hand | 54/58 | €35,378 | €58,129 | +€22,751 | +64.3% |
| Total equity and liabilities | 10/49 | €35,378 | €58,129 | +€22,751 | +64.3% |
| Equity | 10/15 | €27,825 | €49,770 | +€21,945 | +78.9% |
| Contributions | 10/11 | €6,000 | €6,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €21,825 | €43,770 | +€21,945 | +101% |
| Amounts payable | 17/49 | €7,553 | €8,359 | +€806 | +10.7% |
| Amounts payable within one year | 42/48 | €7,553 | €8,359 | +€806 | +10.7% |
| Trade debts | 44 | €411 | €806 | +€396 | +96.3% |
| Suppliers | 440/4 | €411 | €806 | +€396 | +96.3% |
| Taxes, remuneration and social security | 45 | €437 | €2,472 | +€2,035 | +465% |
| Taxes | 450/3 | €437 | €2,472 | +€2,035 | +465% |
| Other amounts payable | 47/48 | €6,705 | €5,081 | -€1,625 | -24.2% |
| Other operating charges | 640/8 | €111 | €570 | +€459 | +413% |
| Gross operating margin | 9900 | €30,012 | €32,268 | +€2,256 | +7.5% |
| Operating profit (loss) | 9901 | €29,901 | €31,698 | +€1,797 | +6.0% |
| Financial income | 75/76B | - | €1 | +€1 | |
| Recurring financial income | 75 | - | €1 | +€1 | |
| Financial charges | 65/66B | €138 | €78 | -€60 | -43.5% |
| Recurring financial charges | 65 | €138 | €78 | -€60 | -43.5% |
| Profit (loss) for the period before taxes | 9903 | €29,762 | €31,620 | +€1,858 | +6.2% |
| Income taxes | 67/77 | €7,937 | €9,675 | +€1,738 | +21.9% |
| Profit (loss) for the period | 9904 | €21,825 | €21,945 | +€120 | +0.6% |
| Profit (loss) for the period to be appropriated | 9905 | €21,825 | €21,945 | +€120 | +0.6% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.